Globus Medical (GMED) Receivables (2011 - 2026)

Globus Medical has reported Receivables for 16 years, with the latest figure at $686.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 28.28% year-over-year to $686.4 million; the trailing twelve-month figure through Mar 2026 stood at $686.4 million (up 28.28% YoY), and the FY2025 full-year result was $678.9 million, up 21.74% from the prior year.
• Receivables for Q1 2026 stood at $686.4 million, up from $678.9 million in the prior quarter.
• The five-year high for Receivables was $686.4 million in Q1 2026, with the low at $166.2 million in Q1 2022.
• Historically, Receivables has averaged $450.7 million across 5 years, with a median of $534.3 million in 2024.
• Annual changes were most pronounced in 2024 — Receivables surged 154.71% — and 2025, when it retreated 0.04%.
• Globus Medical's Receivables stood at $213.2 million in 2022, then surged by 135.99% to $503.2 million in 2023, then rose by 10.82% to $557.7 million in 2024, then climbed by 21.74% to $678.9 million in 2025, then grew by 1.1% to $686.4 million in 2026.
• The last three Receivables figures came in at $686.4 million (Q1 2026), $678.9 million (Q4 2025), and $619.1 million (Q3 2025), per Business Quant data.